ProlX Pharmaceuticals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

ProlX Pharmaceuticals General Information

Description

Operator of a biopharmaceutical firm developing and producing pharmaceutical products for the healthcare industry based in Tucson, Arizona. The company is engaged in the development of novel therapeutics for the treatment of cancer, creating innovative pharmaceutical solutions to address various medical needs and improve patient outcomes.

Contact Information

Website
www.prolx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 221 East 6th Street
  • Tucson, AZ 85705
  • United States
+1 (520)
Primary Industry
Drug Discovery
Parent Company
Cascadian Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 221 East 6th Street
  • Tucson, AZ 85705
  • United States
+1 (520)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProlX Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProlX Pharmaceuticals‘s full profile, request access.

Request a free trial

ProlX Pharmaceuticals FAQs

  • When was ProlX Pharmaceuticals founded?

    ProlX Pharmaceuticals was founded in 1996.

  • Where is ProlX Pharmaceuticals headquartered?

    ProlX Pharmaceuticals is headquartered in Tucson, AZ.

  • What industry is ProlX Pharmaceuticals in?

    ProlX Pharmaceuticals’s primary industry is Drug Discovery.

  • Is ProlX Pharmaceuticals a private or public company?

    ProlX Pharmaceuticals is a Private company.

  • What is the current valuation of ProlX Pharmaceuticals?

    The current valuation of ProlX Pharmaceuticals is .

  • What is ProlX Pharmaceuticals’s current revenue?

    The current revenue for ProlX Pharmaceuticals is .

  • When was ProlX Pharmaceuticals acquired?

    ProlX Pharmaceuticals was acquired on 30-Oct-2006.

  • Who acquired ProlX Pharmaceuticals?

    ProlX Pharmaceuticals was acquired by Cascadian Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process